Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift

A Randomized, Controlled Study to Evaluate Safety and Efficacy of Fibrin Sealant VH S/D 4 S-APR (Artiss) for Tissue Adherence and Hemostasis and To Improve Wound Healing in Subjects Undergoing Endoscopic Browlift

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01320514

Enrollment

Registered

2011-03-22

Start date

2010-12-31

Completion date

2011-05-31

Last updated

2011-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compare Ecchymosis and Edema for Fibrin Sealant and no Fibrin Sealant

Brief summary

The primary objective is to evaluate the safety and efficacy of Artiss (Fibrin Sealant) in reducing the incidence of early postoperative bruising and swelling.

Interventions

DRUGFibrin Sealant (Artiss)

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Subjects planned for endoscopic browlift, subjects who read, understand and sign the written informed consent, healthy female or male subjects, 18-75 years old, and subjects who are able and willing to comply with the protocal requirements

Exclusion criteria

* Subjects who had previous browlift, subjects indicated for concurrent facial surgeries, subjects considered to be active smokers, subjects with ecchymosis/edema on day 0, significant laboratory abnormalities, subjects with known bleeding or coagulation disorders, subjects treated with anti-coagulants.

Design outcomes

Primary

Measure	Time frame
Comparison of ecchymosis and edema	30 days

Secondary

Measure	Time frame
Resolution of ecchymosis and edema, incidence of hematoma/seroma	30 days

Countries

United States

Contacts

Primary ContactDavis B Nguyen, MD

nguyendavisb@yahoo.com310 550 0288

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026